ANTIBIOTICS | ||
S. No. | Generic Name | Composition |
1 | CEFIXIME & LACTIC ACID BACILLUS FOR ORAL SUSPENSION (50mg + 60 million spores) | Each 5 ml (after reconstitution) contains :
Cefixime Trihydrate I.P. eq. to Anhydrous Cefixime 50 mg Lactic Acid Bacillus 60 Million Spores Excipients q.s. |
2 | CEFIXIME & POTASSIUM CLAVULANATE FOR ORAL SUSPENSION IP (50mg+31.25mg) | Each 5 ml (after reconstitution) contains :
Cefixime Trihydrate I.P. eq. to Anhydrous Cefixime 50 mg PotassiumClavulanate IP (as Potassium Clavulanate Diluted IP) Eq. to Clavulanic Acid 31.25 mg In a flavoured palatable base q.s. Colour : Ponceau-4R |
3 | CEFPODOXIME PROXETIL FOR ORAL SUSPENSION IP (50mg) | Each 5 ml (after reconstitution) contains :
Cefpodoxime Proxetil I.P. eq. to Cefpodoxime 50 mg Excipients q.s. In a flavoured palatable base Colour : Sunset Yellow FCF |
4 | CEFPODOXIME PROXETIL FOR ORAL SUSPENSION IP (100mg) | Each 5 ml (after reconstitution) contains :
Cefpodoxime Proxetil I.P. eq. to Cefpodoxime 100 mg Excipients q.s. In a flavoured palatable base Colour : Sunset Yellow FCF |
5 | AMOXYCILLIN & POTASSIUM CLAVULANATE FOR ORAL SUSPENSION IP (200mg+28.5mg) | Each 5 ml (after reconstitution) contains :
Amoxycillin Trihydrate IP Eq. to Amoxycillin 200 mg PotassiumClavulanate IP (as Potassium Clavulanate Diluted IP) Eq. to Clavulanic Acid 28.5 mg Excipients q.s In a flavoured palatable base Colour : Sunset Yellow FCF |
6 | CEFIXIME FOR ORAL SUSPENSION 50 MG/5 ML | Each 5 ml (after reconstitution) contains :
Cefixime Trihydrate USP eq. to Anhydrous Cefixime 50 mg Excipients q.s. Colour : Sunset Yellow FCF |
7 | CEFIXIME FOR ORAL SUSPENSION 25 MG/5 ML | Each 5 ml (after reconstitution) contains :
Cefixime Trihydrate USP eq. to Anhydrous Cefixime 25 mg Excipients q.s. Colour : Sunset Yellow FCF |
8 | CEFIXIME & LACTIC ACID BACILLUS FOR ORAL SUSPENSION (50mg + 20 million spores) | Each 5 ml (after reconstitution) contains :
Cefixime Trihydrate I.P. eq. to Anhydrous Cefixime 50 mg Lactic Acid Bacillus 20 Million Spores Excipients |
9 | CEFIXIME & LACTIC ACID BACILLUS FOR ORAL SUSPENSION (50mg + 60 million spores) | Each 5 ml (after reconstitution) contains :
Cefixime Trihydrate I.P. eq. to Anhydrous Cefixime 50 mg Lactic Acid Bacillus 60 Million Spores Excipients q.s |
10 | CEFPODOXIME PROXETIL & POTASSIUM CLAVULANATE FOR ORAL SUSPENSION IP (50mg+31.25mg) | Each 5 ml (after reconstitution) contains :
Cefpodoxime Proxetil I.P. eq. to Cefpodoxime 50 mg PotassiumClavulanate IP (as Potassium Clavulanate Diluted IP) Eq. to Clavulanic Acid 31.25 mg Excipients q.s In a flavoured palatable base Colour : Sunset Yellow FCF |
11 | CEFPODOXIME PROXETIL & POTASSIUM CLAVULANATE FOR ORAL SUSPENSION IP (100mg+62.5mg) | Each 5 ml (after reconstitution) contains :
Cefpodoxime Proxetil I.P. eq. to Cefpodoxime 100 mg PotassiumClavulanate IP (as Potassium Clavulanate Diluted IP) Eq. to Clavulanic Acid 62.5 mg Excipients q.s In a flavoured palatable base Colour : Sunset Yellow FCF |
12 | CEFUROXIME AXEIL FOR ORAL SUSPENSION USP (125mg) | Each 5 ml (after reconstitution) contains :
Cefuroxime Axetil I.P. eq. to Cefuroxime 125 mg Excipients q.s. Colour : Sunset Yellow FCF |
13 | CEFACLOR FOR ORAL SUSPENSION I.P (125mg) | Each 5 ml (after reconstitution) contains :
Cefaclor I.P. eq. to anhydrous Cefaclor 125 mg Excipients q.s. Colour : Erythrosine |
14 | OFLOXACIN, METRONIDAZOLE & LACTIC ACID BACILLUS SUSPENSION (100mg+200mg+50 million spores) | Each 5 ml contains :
Ofloxacin I.P. 100 mg Metronidazole Benzoate I.P. Eq. to Metronidazole 200 mg Lactic Acid Bacillus 60 Million Spores In a flavoured Syrupy Base q.s. Colour : Sunset Yellow FCF |
15 | AZITHROMYCIN ORAL SUSPENSION I.P 200 MG/5 ML | Each 5 ml contains :
Azithromycin I.P. 200 mg In a flavoured syrupy base q.s. Colour : Quinoline Yellow |
16 | OFLOXACIN & METRONIDAZOLE ORAL SUSPENSION (100mg+200mg) | Each 5 ml contains
Ofloxacin i.p–100mg Metronidazole Benzoate i.p eq. to Metronidazole–200 mg In a flavured syrupy base q.s Colour: tartrazine |
17 | NORFLOXACIN & TINIDAZOLE ORAL SUSPENSION (100mg+150mg) | Each 5 ml contains
Norfloxacin i.p–100mg Tinidazole i.p–150 mg In flavured syrupy base q.s Colour: Sunset Yellow |
18 | CEFUROXIME AXETIL & POTASSIUM CLAVULANATE ORAL SUSPENSION | Each 5 ml of reconstituted suspension contains :
Cefuroxime Axetil I.P. e.q. tp Cefuroxime 125 mg Potassium Clavulanate Diluted I.P. e.q.to Clavulanic Acid 31.25 mg In a Palatable suspension base q.s. Colour : Approved colours used. |
19 | AZITHROMYCIN ORAL SUSPENSION 200 MG | Each 5 ml of reconstituted suspension contains :
Azithromycin (As Dihydrate) I.P. e.q. to Azithromycin 200 mg In a Palatable suspension base q.s. Colour : Approved colours used. |
20 | CEFPODOXIME PROXETIL & POTASSIUM CLAVULANATE ORAL SUSPENSION | Each 5 ml of reconstituted suspension contains :
Cefpodoxime Proxetil I.P. Eq.to Cefpodoxime 50 mg Potassium Clavulnate Diluted I.P. Eq.to Clavulanic Acid 31.55 mg In a Palatable suspension base q.s. Colour : Approved colours used. |
21 | AMOXYCILLIN & POTASSIUM CLAVULANATE ORAL SUSPENSION I.P (400 MG+ 57 MG) | Each 5 ml reconstituted suspension contains :
Amoxycillin Trihydrate I.P. Eq. to Amoxycillin 400 mg Potassium Clavulanate Diluted I.P. Eq. to Clavulanic Acid 57 mg In a Palatable suspension base q.s. Colour : Approved colours used |
22 | CEPODOXINE PROXETIL & POTASSIUM CLAVULANATE ORAL SUSPENSION | Each 5 ml of reconstituted suspension contains :
Cefpodoxime Proxetil I.P. Eq.to Cefpodoxime 100 mg Potassium Clavulnate Diluted I.P. Eq.to Clavulanic Acid 125 mg In a Palatable suspension base q.s. Colour : Approved colours used. |
23 | AMOXYCILLIN & POTASSIUM CLAVULANATE ORAL SUSPENSION I.P (80 MG + 11.4 MG) | Each 5 ml of reconstituted suspension contains :
Amoxycillin Trihydrate I.P. e.q. to Amoxycillin 80 mg Potassium Clavulanate Diluted I.P. Eq. to Clavulanic Acid 11.4 mg In a Palatable suspension base q.s. Colour : Approved colours used. |
24 | AMOXYCILLIN & POTASSIUM CLAVULANATE ORAL SUSPENSION I.P 200 MG +28.5 MG) | Each 5 ml of reconstituted
Suspension contains Amoxycillin Trihydrate I.P. e.q. to Amoxycillin 200 mg Potassium Clavulanate Diluted I.P. Eq. to Clavulanic Acid 28.5 mg In a Palatable suspension base q.s. Colour : Approved colours used. |
25 | AZITHROMYCIN ORAL SUSPENSION I.P 100 MG/5 ML | Each 5 ml contains
Azithromycin i.p—100mg In a flavured syrupy base q.s Colour: Quinoline Yellow |
26 | OFLOXACIN ORAL SUSPENSION I.P 50 MG/5ML | Each 5 ml contains:
Ofloxacin i.p—50 mg In a flavoured syrupy base q.s Colour:- Sunset Yellow FCF |
27 | OFLOXACIN ORAL SUSPENSION I.P 100 MG/5ML | Each 5 ml contains:
Ofloxacin i.p—100 mg In a flavoured syrupy base q.s Colour:- Sunset Yellow FCF |
28 | AMOXYCILLIN & POTASSIUM CLAVULANATE & LACTIC ACID BACILLUS ORAL SUSPENSION | Each 5 ml of reconsituted suspension contains:
Amoxycillin Trihydrate i.p eq. to A,oxycillin—200 mg Potassium Clavulanate Diluted i.p eq. to Clavulanaic Lactic acid bacillus In a palatable suspension base–q.s Colour: Approved colour used. |
29 | AMOXYCILLIN & POTASSIUM CLAVULANATE ORAL SUSPENSION | Each ml of reconsituted suspension contains:
Amoxycillin Trihydrate i.p eq. to Amoxycillin—80 mg Potassium Clavulanate Diluted i.p eq. to Clavulanic acid—11.4 In a palatable suspension base–q.s Colour: Approved colour used |
30 | CEFPODOXIME PROXETILE ORAL SUSPENSION IP | Each ml of reconstituted suspension contains:
Cefpodoxime Proxetile IP eq. to Cefpodoxime—25 mg Excipients:q.s Colour: Approved colour used. |
31 | Azithromycin Syrup | Each 5ml contains:
Azithromycin Dihydrate I.P eq. to Anhydrous Azithromycin—100mg In a flavoured sugar free base—q.s colour: Approved colour used. |
32 | CEFACLOR FOR ORAL SUSPENSION I.P | Each 5 ml constitute suspension contains:
Cefaclor IP eq. to Anhydrous Cefaclor—125 mg In a flavoured suspension base—q.s Colour: Approved colour used. |
33 | AMOXYCILLIN FOR ORAL SUSPENSION I.P 250 mg | Each 5 ml reconstituted suspension contains :
Amoxycillin Trihydrate I.P. Eq. to Amoxycillin—250 mg Excipients—q.s In a flavoured Palatable base Colour: Approved colour used. |
34 | AMOXYCILLIN & POTASSIUM CLAVULANATE FOR ORAL SUSPENSION I.P | Each 5 ml of reconstituted suspension contains:
Amoxycillin Trihydrate I.P eq. to Amoxycillin—125 mg Potassium Clavulanate Diluted I.P eq. to Clavulanic Acid—31.25 mg Excipients—q.s In a flavoured palatable base Colour: Approved colour used. |
35 | AMOXYCILLIN & POTASSIUM CLAVULANATE ORAL SUSPENSION I.P (400 MG+ 57 MG) | Each 5 ml reconstituted suspension contains :
Amoxycillin Trihydrate I.P. Eq. to Amoxycillin 400 mg Potassium Clavulanate Diluted I.P. Eq. to Clavulanic Acid 57 mg In a Palatable suspension base q.s. Colour : Approved colours used |
36 | AMOXYCILLIN & POTASSIUM CLAVULANATE ORAL SUSPENSION I.P (400 MG+ 57 MG) | Each 5 ml reconstituted suspension contains :
Amoxycillin Trihydrate I.P. Eq. to Amoxycillin 80 mg Potassium Clavulanate Diluted I.P. Eq. to Clavulanic Acid 11.4 mg In a Palatable suspension base q.s. Colour : Approved colours used |
37 | AZITHROMYCIN SUSPENSION 100 MG / 5 ML | Each 5 ml contains:
Azithromycin I.P—100 mg In a flavured syrupy base—q.s Colour: Quinoline Yellow |
38 | CEFIXIME FOR ORAL SUSPENSION 100 MG/5 ML IP | Each 5 ml (after reconsitution) contains:
Cefixime Trihydrate IP eq. to Anhydrous Cefixime—100 mg Excipients—q.s Colour: Approved colour used. |
39 | CEFIXIME FOR ORAL SUSPENSION 25 MG/5 ML IP | Each ml (after reconsitution) contains:
Cefixime Trihydrate IP eq. to Anhydrous Cefixime—25 mg Excipients—q.s Colour: Approved colour used. |
40 | AMOXYCILLIN & POTASSIUM CLAVULANATE ORAL SUSPENSION I.P (80+11.4 MG) | Each ml of reconstituted suspension contains:
Amoxycillin Trihydrate I.P eq. To Amoxycillin—80 mg Potassium Clavulanate Diluted I.P eq. to Clavulanic Acid—11.4 mg in a Palatable suspension base—q.s Colour: Approved colour used. |
41 | AMOXICILLIN & POTASSIUM CLAVULANATE ORAL SUSPENSION USP | Each 5 ml of reconstituted suspension contains:
Amoxycillin Trihydrate USP eq. To Amoxycillin—200 mg Potassium Clavulanate Diluted B.P eq. to Clavulanic Acid—28.5 mg Excipients—q.s Colour: Approved colour used. |
42 | AMOXICILLIN & POTASSIUM CLAVULANATE ORAL SUSPENSION USP | Each 5 ml of reconstituted suspension contains:
Amoxycillin Trihydrate USP eq. To Amoxycillin—400 mg Potassium Clavulanate Diluted B.P eq. to Clavulanic Acid—57 mg Excipients—q.s Colour: Approved colour used. |
43 | CEFIXIME FOR ORAL SUSPENSION USP
| Each 5 ml of reconsitituted suspension contains:
Cefixime Trihydrate USP eq. to Anhydrous Cefixime—100 mg Excipients—q.s Colour: Sunset Yellow FCF |
44 | CEFPODOXIME FOR ORAL SUSPENSION USP
| Each 5 ml of reconsitituted suspension contains:
Cefpodoxime Proxetile USP eq. to Cefpodoxime—50 mg Excipients—q.s In a flavoured base Colour: Sunset Yellow FCF |
45 | CEFIXIME FOR ORAL SUSPENSION 50 MG/5 ML I.P | Each 5 ml (after reconsitution) contains:
Cefixime Trihydrate IP eq. to Anhydrous Cefixime—50 mg Excipients—q.s Colour: Sunset Yellow FCF |
46 | AZITHROMYCIN FOR ORAL SUSPENSION USP | Each 5 ml of reconsitituted suspension contains:
Azithromycin USP (as dihydrate) eq. to Azithromycin—200 mg Excipients—q.s |
47 | AZITHROMYCIN USP ORAL SUSPENSION | Each 5ml of reconstituted suspension contains:
Azithromycin USP (as dihydrate) eq. to Azithromycin—200 mg Excipients–q.s |
48 | CIPROFLOXACIN ORAL SUSP
| Each 5 ml contains:
Ciprofloxacin Hydrochloride BP eq. to Ciprofloxacin—125 mg In a flavoured syrup base—q.s Colour: Approved colour used |
49 | CIPROFLOXACIN & METRONIDAZOLE ORAL SUSP
| Each 5 ml contains:
Ciprofloxacin Hydrochloride BP eq. to Ciprofloxacin—125 mg Metronidazole Benzoate BP eq. to Metronidazole—200 mg In a flavoured syrup base—q.s Colour: Approved colour used |
50 | AMOXYCILLIN FOR ORAL SUSP.
| Each 5 ml of reconstituted suspension contains:
Amoxycillin Trihydrate USP eq. to Amoxycillin—125 mg Excipients—q.s Colour: Approved colour used. |
51 | CEFDINIR ORAL SUSPENSION IP 125 MG PER 5 ML | Each 5 ml Re-constituted suspension contains:
Cefdinir IP—125 mg Excipients—q.s Colour: Approved colour used. |
52 | AMOXYCILLIN 200 MG, CLAVULANIC ACID 28.5 MG AND LACTIC ACID BACILLUS 30 MILLION SPORES DRY SYRUP | Each 5 ml unconstituted suspension contains:
Amoxycillin Trihydrate IP eq. to Amoxycillin—200 mg Poptassium Clavulanate eq. to Clavulanic Acid—28.5 mg Lactic Acid Bacillus—30 Million Spores Excipients—q.s Colour: Approved colour used. |
53 | CLARITHROMYCIN FOR ORAL SUSPENSION USP | Each 5 ml of the reconsituted suspension contains:
Clarithromycin I.P—125 mg Excipients—q.s In a flavoured base—q.s Colour: Approved colour used. |
54 | LINEZOLID FOR ORAL SUSPENSION | Each 5 ml of constituted suspension contains:
Linezolid I.P—100 mg Excipients—q.s In a flavoured base Colour: Approved colour used. |
55 | AMOXYCILLIN 200 MG, CLAVULANIC ACID 28.5 MG AND LACTIC ACID BACILLUS 60 MILLION SPORES DRY SYP | Each 5 ml re-constituted suspension contains:
Amoxycillin Trihydrate IP eq. to Anhydrous Amoxycillin—200mg Potassium Clavulanate eq. to Clavulanic Acid—28.5 mg Lactic Acid Bacillus—60 Million Spores Excipients—q.s Colour: Approved colour used. |
56 | ERYTHROMYCIN ESTOLATE ORAL SUSPENSION USP | Each 5 ml contains:
Erythromycin Esolate USP eq. to Erythromycin—125 mg Excipients—q.s In a flavoured syrupy base—q.s Colour: Approved colour used. |
57 | ERYTHROMYCIN ESTOLATE ORAL SUSPENSION USP | Each 5 ml contains:
Erythromycin Esolate USP eq. to Erythromycin—125 mg Excipients—q.s In a flavoured syrupy base—q.s Colour: Approved colour used. |
58 | TRIMETHOPRIM & SULPHAMETHOXAZOLE ORAL SUSPENSION IP | Each 5 ml contains:
Trimethoprim IP—40 mg Sulphamethozazole IP—200 mg In flavoured sorbitol base—q.s Colour: Approved colour used. |
59 | CEPHALEXIN FOR ORAL SUSPENSION IP | Each 5 ml of reconsituted suspension contains:
Cephalexin IP eq. to Anhydrous Cephalexin—250 mg In a flavoured base Colour: Susnset Yellow FCF |
60 | ERYTHROMYCIN STEARATE SUSPENSION
(FOR EXPORT ONLY) | Each 5 ml of the reconsituted suspension contains:
Erythromycin Stearate BP—200 mg Excipients—q.s In a flavoured base—q.s Colour: Approved colour used. |
61 | SULTAMICILLIN FOR ORAL SUSPENSION
(FOR EXPORT ONLY ) | Each 5 ml of reconstituted suspension contains:
Sultamicilin BP—250 mg Excipients—q.s Colour: Approved colour used |
62 | AMOXICILLIN & POTASSIUM CLAVULANATE ORAL SUSPENSION USP
( FOR EXPORT ONLY) | Each 5 ml of reconsitituted suspension contains:
Amoxicillin Trihydrate USP eq. to Amoxicillin—250 mg Potassium Clavulanate Diluted USP eq. to Clavulanic Acid—62.5 mg Excipients—q.s Colour: Approved colour used. |
63 | AMOXICILLIN & POTASSIUM CLAVULANATE ORAL SUSPENSION USP
( FOR EXPORT ONLY) | Each 5 ml of reconsitituted suspension contains:
Amoxicillin Trihydrate USP eq. to Amoxicillin—600 mg Potassium Clavulanate Diluted USP eq. to Clavulanic Acid—42.9 mg Excipients—q.s Colour: Approved colour used. |
64 | CEFUROXIME AXETILE FOR ORAL SUSPENSION USP
( FOR EXPORT ONLY) | Each 5 ml of reconstituted suspension contains:
Cefuroxime Axetile USP eq. to Cefuroxime—250 mg Excipients—q.s Colour: Approved colour used. |
65 | CEFADROXILFOR ORAL SUSPENSION USP 250 MG / 5 ML
(FOR EXPORT ONLY) | Each 5 ml of reconstituted suspension contains:
Cefadroxil USP eq to Cefadroxil—250 mg Excipients—q.s Colour: Approved colour used. |
ANTIMICROBIAL AND ANTIBACTERIAL | ||
S. No. | Generic Name | Composition |
1 | ALBENDAZOLE ORAL SUSPENSION I.P 200 MG/5 ML | Each 5 ml contains
Albendazole i.p—200mg In a flavured non-syrupy base q.s Colour: Sunset Yellow FCF |
2 | IVERMECTIN & ALBENDAZOLE ORAL SUSPENSION | each 10ml contains
Ivermectin i.p—3 mg Albendazole i.p—400mg In a flavured non-syrupy base q.s Colour: Sunset yellow FCF |
3 | CHLORHEXADINE GLUCONATE & ISOPROPYL ALCOHOL SOLUTION | Composition:
Chlorhexidine Gluconate Solution IP— 2.5% w/v (Eq. to Chlorhexidine Gluconate 0.5 %) Isopropyl Alcohol IP— 70% v/v In a flavoured syrypy base—q.s Colour: Approved colour used |
4 | CHLORHEXIDINE MOUTH WASH I.P | Chlorhexidine Gluconate Solution I.P
eq. to Chlorhexadine Gluconate 0.2% w/v Aqueous Base—q.s Colour: Approved colour used. |
5 | FURAZOLIDONE ORAL SUSPENSION IP | Each 5 ml contains:
Furazolidone I.P—25 mg In flavoured syrupy base Colour: Approved colour used. |
6 | BENZYDAMINE HCL & CHLORHEXIDINE MOUTH WASH | Each 15 ml contains:
Benzydamine Hcl B.P—22.5 mg Chlorhexidine Gluconate solution IP eq. to Chlorhexidine—18 mg In flavoured aqueous base Colour: Approved colour used. |
7 | FURAZOLIDONE ORAL SUSPENSION USP | Each 15 ml Contains:
Furazolidone USP—50 mg Excipients—q.s In a flavoured portable base |
8 | BENZYDAMINE HCL & CHLORHEXIDINE MOUTH WASH | Each 5 ml contains:
Melatonin B.P—3 mg In a flavoured syrupy base—q.s colour: Approved colour used |
9 | CHLORHEXIDINE GLUCONATE, SODIUM FLUORIDE & ZINC CHLORIDE MOUTHWASH | Chlorhexidine Gluconate Solution I.P
eq. to Chlorhexadine Gluconate 0.20% w/v Sodium Fluoride I.P—0.05% w/v Zinc Chloride I.P—0.09% w/v In a plesantaly flavoured Aqueous Base—q.s Colour: Approved colour used. |
10 | METRONIDAZOLE ORAL SUSP | Each 5ml contains:
Metronidazole Benzoate BP eq . To Metronidazole—200 mg In a flavoured syrupy base—q,s Colour: Approved colour used. |
ANTIHISTAMINIC | ||
S. No. | Generic Name | Composition |
1 | CYPROHEPTADINE HYDROCHLORIDE SYRUP I.P 2MG/5ML | Each 5ml contains
Cyproheptadine Hydrochloride i.p—2 mg In a flavured sorbitol base q.s Colour: Sunset Yellow FCF |
2 | CYPROHEPTADINE HYDROCHLORIDE & TRICHOLINE CITRATE SYRUP | Each 5ml contains
Cyproheptadine Hydrochloride i.p—2 mg Tricholine Citrate—275mg In a flavured sorbitol base q.s Colour: Caramel i.p |
3 | FEXOFENADINE HYDROCHLORIDE ORAL SUSPENSION | Each 5 ml contains:-
Fexofenadine Hydrochloride i.p—30 mg in a flavoured syrupy base q.s Colour: Titanium Dioxide i.p |
4 | MONTELUKAST SODIUM & LEVOCETIRIZINE DIHYDROCHLORIDE SYRUP | Each 5 ml contains:
Levocetirizine Dihydrochloride i.p –2.5 mg Montelukast—4 mg In a flavoured syrupy base q.s Colour: Tartrazine |
5 | LEVOCETIRIZINE DIHYDROCHLORIDE SYRUP | Each 5 ml contains:
Levocetirizine Dihydrochloride i.p 2.5 mg Pleasantly flavoured syrupy base q.s Colour: Tartrazine |
6 | CETIRIZINE ORAL SOLUTION I.P | Each 5 ml contains:
Cetirizine Hydrochloride i.p 5 mg in a pleasantly flavoured Colour: Quinolline Yellow |
7 | CYPROHEPTADINE HYDROCHLORIDE & TRICHOLINE CITRATE SYRUP | Each 5ml contains:
Cyproheptadine Hydrochloride I.P eq. to Anhydrous Cyproheptadine Hydrochloride—2 mg Tricholine Citrate 65%—275 mg In a flavoured non syrupy base—q.s Colour: Approved colour used. |
8 | HYDROXYZINE ORAL SOLUTION I.P | Each 5 ml Contains:
Hydroxyzine Hydrochloride I.P—10 mg In flavoured syrupy base |
9 | FEXOFENADINE HYDROCHLORIDE ORAL SUSPENSION | Each 5 ml contains:
Fexofenadine Hydrochloride I.P—30 mg In a flavoured syrupy base—q.s Colour: Approved colour used. |
10 | LEVOCETIRIZINE DIHYDROCHLORIDE SYRUP | Each 5 ml contains:
Levocetirizine Dihydrochloride IP—5 mg In a flavoured syrupy base Colour: Approved colour used |
11 | FEXOFENADINE HYDROCHLORIDE & MONTELUKAST SODIUM SUSPENSION | Each 5 ml contains:
Fexofenadine Hydrochloride I.P—30 mg Montelukast Sodium I.P eq. to Montelukast—4 mg In a flavoured syrupy base—q.s Colour: Approved colour used. |
12 | FEXOFENADINE HYDROCHLORIDE & MONTELUKAST SODIUM SUSPENSION | Each 5 ml contains:
Fexofenadine Hydrochloride I.P—60 mg Montelukast Sodium I.P eq. to Montelukast—4 mg In a flavoured syrupy base—q.s Colour: Approved colour used. |
13 | MONTELUKAST SODIUM & LEVOCETIRIZINE DIHYDROCHLORIDE SYRUP | Each 5 ml contains:
Montelukast—4 mg Levocetirizine Dihydrochloride IP—2.5 mg In a falvoured surupy base—q.s Colour: Tartrazine |
ANTIPYRETIC | ||
S. No. | Generic Name | Composition |
1 | PAEDIATRIC PARACETAMOL ORAL SUSPENSION I.P 125 MG/5 ML | Each 5ml contains
paracetamol i.p–125mg In a flavured syrupy base q.s Colour: Erythrosine |
2 | PAEDIATRIC PARACETAMOL ORAL SUSPENSION I.P 250 MG/5 ML | Each 5ml contains
paracetamol i.p–250mg In a flavured syrupy base q.s Colour: Erythrosine |
3 | PARACETAMOL PEDIATRIC ORAL SUSPENSION IP | Each ml (approx..20 drops)contains:
Paracetamol I.P—150 mg In a flavoured syrupy base—q.s Colour: Approved colour used. |
4 | PARACETAMOL PEDIATRIC ORAL SUSPENSION IP | Each ml (approx..20 drops)contains:
Paracetamol I.P—150 mg In a flavoured syrupy base—q.s Colour: Approved colour used. |
5 | PARACETAMOL SYRUP 125 MG/ 5 ML | Each 5 ml contains:
Paracetamol IP—125 mg In a flavoured syrupy base—q.s Colour: Approved colour used |
6 | PARACETAMOL SYRUP 125 MG/ 5 ML | Each 5 ml contains:
Paracetamol IP—125 mg In a flavoured syrupy base—q.s Colour: Approved colour used |
COUGH | ||
S. No. | Generic Name | Composition |
1 | DEXTROMETHORPHAN HYDROBROMIDE , PHENYLEPHRINE HYDROCHLORIDE & CHLORPHENRAMINE MALEATE SYRUP | Each 5ml contains
Dextromethorphan hydrobromide i.p–15 mg Phenylpherine Hydrochloride i.p–5 mg Chlorpheniramine Maleate i.p–2 mg In a flavured syrupy base q.s Colour:- Ponceau-4R |
2 | AMBROXOL HYDROCHLORIDE, GUAIFENESIN, TERBUTALINE SULFATE & MENTHOL SYRUP | Each 5ml contains
Ambroxol Hydrochloride i.p–15mg Guaifenesin i.p—50mg Terbutaline Sulfate i.p—1.25mg Menthol i.p—2.5mg In a flavuredd syrupy base q.s Colour:- Poncea-4R |
3 | LEVOSULBUTAMOL SULPHATE, AMBROXOL HYDROCHLORIDE & GUAIPHENESIN SYRUP | Each 5 ml contains:
Levosalbutamol Sulphate IP eq. to Levosulbutamol—0.25 mg Ambroxol Hydrochloride I.P—7.50 mg Guaiphenesin I.P—12.50 mg Flavoured Syrupy Base—q,s Colour: Approved Colour Used. |
4 | AMBROXOL HYDROCHLORIDE, GUAIPHENESIN & LEVOSULBUTAMOL SYRUP | Each 5 ml contains:
Ambroxol Hydrochloride I.P—15 mg Guaiphenesin I.P—50 mg Levosulbutamol Sulphate I.P eq. to Levosulbutamol —0.5 mg In a flavboured syrupy base—q.s Colour: Approved Colours Used |
5 | BROMHEXINE HCL, DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE, GUAIFENESIN SYRUP
| Composition:
Chlorhexidine Gluconate Solution IP— 2.5% w/v (Eq. to Chlorhexidine Gluconate 0.5 %) Isopropyl Alcohol IP— 70% v/v In a flavoured syrypy base—q.s Colour: Approved colour used |
6 | AMBROXOL HYDROCHLORIDE, GUAIPHENESIN & LEVOSULBUTAMOL SYRUP | Each 5 ml contains:
Ambroxol Hydrochloride I.P—30 mg Guaiphenesin I.P—50 mg Levosulbutamol Sulphate I.P eq. to Levosulbutamol —1 mg In a flavoured syrupy base—q.s Colour: Approved Colours Used |
7 | DEXTROMETHORPHAN HYDROBROMIDE , CHLORPHENRAMINE MALEATE SYRUP | Each 5ml contains:
Dextromethrophan Hydrochloride I.P—10 mg Chlorpheniramine Maeleate I.P—2 mg In a flavoured syrupy base—q.s Colour: Approved colour used. |
8 | AMBROXOL HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN SYRUP | Each 5ml contains:
Ambroxol Hydrochloride I.P—30 mg Terbutaline Sulphate I.P—2.5 mg Guaiphenesin I.P—100 mg In a flavoured syrupy base. Colour: Approved colour used. |
9 | BROMHEXINE HCL SYRUP | Each 5 ml contains:
Bromhexine Hcl I.P—4 mg In a flavoured syrupy base—q.s Colour: Approved colour used. |
10 | NOSCAPINE, AMMONIUM CHLORIDE & SODIUM CITRATE ORAL SUSPENSION | Each 5 ml contains:
Noscapine I.P—7 mg Ammonium Chloride I.P—28 mg Sodium Citrate I.P—3.25 mg Flavoured syrupy base—q.s Colour: Approved colour used. |
11 | ACEBROPHYLLINE, GUAIPHENESIN & TERBUTALLINE SULPHATE SYRUP | Each 5 ml contains:
Acebrophylline—50 mg Guaiphenesin IP—50 mg Terbutaline Sulphate IP—1.25 mg Mentholated sugar free base Colour: Approved colour used. |
12 | BROMHEXINE ORAL SYRUP
| Each 5 ml contains:
Bromhexine Hcl BP—4 mg In a flavoured syrupy base—q.s Colour: Approved colour used. |
13 | TERBUTALINE SUPHATE, BROMHEXINE HCL GUAIPHENESIN SYRUP | Each 5 ml contains:
Terbutaline Sulphate I.P—1.25 mg Bromhexine Hydrochloride I.P—4 mg Guaiphenesin I.P—50 mg In a flavoured syrupy base—q.s Colour: Approved colour used. |
14 | AMBROXOL HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN & MENTHOL SYRUP | Each 5 ml contains:
Ambroxol Hydrochloride IP—15 mg Terbutaline Sulphate IP—1.25 mg Guaiphenesin IP—50 mg Menthol IP—2.5 mg In a flavoured syrupy base—q.s Colour: Approved colour used |
15 | LEVOCLOPERASTINE FENDIZOATE ORAL SUSPENSION | Each 5 ml suspension contains:
Levocloperastine Fendizoate—35.4 mg (eq. to Levocloperastine Hydrochloride)—20 mg In a flavoured sugar free base Excipients—q.s Colour: Approved colour used. |
ANTICOLD | ||
S. No. | Generic Name | Composition |
1 | PARACETAMOL, PHENYLPHERINE HYDROCHLORIDE & CHLORPHENIRAMINE MALEATE SYP | Each 5ml contains Paracetamol i.p—125mg Phenyephrine Hydrochloride i.p—2.5mg Chlorpheniramine maleate i.p-1mg In a flavured syrupy base q.s Colour: sunset Yellow FCF |
2 | PARACETAMOL, PHENYLEPHERINE HYDCROCHLORIDE, CHLORPHENIRAMINE MALEATE, SODIUM CITRATE SYRUP | Each 5 ml contains: Paracetamol I.P—125 mg Phenylepherine Hydrochloride I.P—5 mg Chlorpheniramine Maeleate I.P—1 mg Sodium Citrate I.P—60 mg In a flavoured surupy base—q.s Colour: Approved colours used. |
3 | LEVOCETIRIZINE DIHYDROCHLORIDE, AMBROXOL HYDROCHLORIDE, PARACETAMOL, PHENYLPHERINE HYDROCHLORIDE, MENTHOL SYRUP | Each 5ml contains: Levocetirizine Dihydrochloride I.P—2.5 mg Ambroxol Hydrochloride I.P—30 mg Paracetamol I.P—250 mg Phenylephirine Hydrochloride I.P—5 mg Menthol I.P—1 mg In a flavoured syrupy base—q.s Colour: Approved colour used. |
4 | LEVOCETIRIZINE DIHYDROCHLORIDE, PARACETAMOL, PHENYLPHERINE HYDROCHLORIDE,SYRUP | Each 5ml contains: Levocetirizine Dihydrochloride I.P—2.5 mg Paracetamol I.P—250 mg Phenylephirine Hydrochloride I.P—2.5 mg In a flavoured syrupy base—q.s Colour: Approved colour used. |
5 | PARACETAMOL, PHENYLEPHRINE HCL, CHLORPHENIRAMINE MALEATE, SODIUM CITRATE & MENTHOL SUSPENSION | Each 5 ml contains: Paracetamol IP—250 mg Phenylephrine hydrochloride IP—5 mg Chlorpheniramine Maleate IP—2 mg Sodium Citrate IP—60 mg Menthol IP—1 mg In a flavoured syrupy base—q.s Colour: approved colour used. |
6 | PARACETAMOL, PHENYLEPHRINE HCL, CHLORPHENIRAMINE MALEATE, SODIUM CITRATE & MENTHOL SUSPENSION | Each 5 ml contains: Paracetamol IP—250 mg Phenylephrine hydrochloride IP—5 mg Chlorpheniramine Maleate IP—2 mg Sodium Citrate IP—60 mg Menthol IP—1 mg In a flavoured syrupy base—q.s Colour: approved colour used. |
VITAMIN & MINERAL SUPPLEMENTS | ||
S. No. | Generic Name | Composition |
1 | MULTIVITAMIN, MULTIMINERAL & ANTIOXIDANTS DROPS (FOR PAEDIATRIC USE) | Each ml contains : (approx. 20 drops) Vitamin A (As Palmitate) I.P. 2500 I.U. Vitamin D3 I.P. 200 I.U. Vitamin E (Tocopheryl Acetate) I.P. 5 I.U. Vitamin B1 I.P. 1 mg Vitamin B2 I.P. 1 mg Vitamin B3 I.P. 10 mg Vitamin B6 I.P. 1 mg Vitamin C I.P. 40 mg D-Panthenol I.P. 3 mg Lysine Hydrochloride U.S.P. 10 mg Chromium Chloride Hexahydrate U.S.P. Eq. to Elemental Chromium 20 mcg Sodium Molybdate Dihydrate B.P. Eq. to Elemental Molybdenum 10 mcg Sodium Selenite Pentahydrate B.P. Eq. to Elemental Selenium 10 mcg Zinc Sulphate I.P. 13.3 mg In a flavoured non-syrupy base q.s. Appropriate overages of vitamin added to compensate for loss on |
2 | CHOLECALCIFEROL ORAL DROPS 400 I.U | Each 0.5 ml contains : Cholecalciferol I.P. 400 I.U. (As Stabilized) In a flavoured non-syrupy base q.s. Appropriate overages of vitamin added to compensate for loss on |
3 | POTASSIUM MAGNESIUM CITRATE WITH VITAMIN B6 ORAL SOLUTION (978mg+14mg) | Each 5 ml contains : Potassium Magnesium Citrate 978 mg Pyridoxine Hydrochloride (Vit B6) I.P. 14 mg In a flavoured non-syrupy base q.s. Colour : Caramel I.P. |
4 | POTASSIUM CITRATE, MAGNESIUM CITRATE & PYRIDOXINE HYDROCHLORIDE ORAL SOLUTION (1100mg+375mg+20mg) | Each 5 ml contains : Potassium Citrate I.P. 1100 mg Magnesium Citrate U.S.P. 375 mg Pyridoxine Hydrochloride (Vit B6) I.P. 20 mg In a flavoured non-syrupy base q.s. Colour : Caramel I.P. |
5 | MULTIVITAMIN, MULTIMINERAL & ANTIOXIDANTS SYRUP (FOR PROPHYLACTIC USE) | Each 5 ml contains : Vitamin A (As Palmitate) I.P. 2000 I.U. Vitamin D3 I.P. 200 I.U. Vitamin E (Tocopheryl Acetate) I.P. 7.5 mg Vitamin B1 I.P. 1.5 mg Vitamin B2 I.P. 2 mg Vitamin B6 I.P. 1 mg Vitamin 12 I.P. 1 mcg Vitamin C I.P. 40 mg D-Panthenol I.P. 2.5 mg Niacinamide I.P. 18.5 mg Lysine Hydrochloride U.S.P. 10 mg Lycopene U.S.P. 10% 1000 mcg Calcium Lactate I.P. Eq. to Elemental Calcium 1.25 mg Potassium Iodide I.P. eq. to Elemental Iodine 50 mcg Chromium Chloride Hexahydrate U.S.P. Eq. to Elemental Chromium 8 mcg Manganese Chloride Tetrahydrate U.S.P. Eq. to Elemental Manganese 8 mcg Sodium Molybdate Dihydrate B.P. Eq. to Elemental Molybdenum 8 mcg Sodium Selenite Pentahydrate B.P. Eq. to Elemental Selenium 10 mcg Zinc Gluconate B.P. Eq. to Elemental Zinc 2 mg In a flavoured non-syrupy base q.s. Colour : Ponceau-4R Appropriate overages of vitamin added to compensate for loss on |
6 | MULTIVITAMIN & MULTIMINERAL SYRUP | Each 5 ml contains Vitamin A (As Palmitate) i.p—1600 iu Vitamin D3 i.p— 200 i.u Vitamin E (Tacophenyl Acetate )i.p— 5 iu Vitamin B1 ip— 1mg Vitamin B2 ip—1mg Vitamin B6 ip—1mg Vitamin B12 p–0.5mcg D-Panthenol i.p—1.5mg Niacinamide i.p—15mg Lysine Hydrochloride usp–5mg Potassium Iodide i.p eq. to Elemental Iodine—50mcg Chromium Chloride Hexahydrate ussp eq. to Elemental Sodium Molybdate Dihydrate b.p eq. to Elemental Sodium Selenite Pentahydrate b.p eq. to Elemental Zinc Sulphate Heptahydrate i.p eq. to Elemental Zinc—11.3mg In a flavured non-syrupy base q.s Colour: Poncea-4R Appropriateoverages of vitamin added to compensate for loss on |
7 | VITAMIN D3 (CHOLECALCIFEROL) DROPS | Each ml contains: Cholecalciferol i.p (As Stabilized) 800 IU In a flavured non-syrupy base q.s Appropriate overages of vitamin added to compensate for loss on |
8 | LYCOPENE, VITAMIN & MINERALS SYRUP | Each 15 ml contains Lycopene usp 10% 2000 mcg Niacinamide i.p–25 mg Pyridoxine Hydrochloride i.p—1.5 mg Vitamin B12 i.p— 1mcg Folic Acid i.p— 100mcg Biotin usp—100mcg Copper Sulphate Pentahydrate b.p eq. to Elemental Potassium Iodide b.p eq. to Elemental Iodide–100 mg Magnesium Gluconate b.p eq.to Elemental Magnsium—3 mg Sodium Selenite Pentahydrate b.p eq. to Elemental Zinc Gluconate b.p eq. to Elemental Zinc–3mg In a flavoured syrupy base q.s Colour: Caramel USP NF Appropriate overages of vitamin added to compensate for loss on |
9 | VITAMIN B-COMPLEX, CHOLINE, MINERALS WITH LYSINE SYRUP | Each 5ml contains: Thiamine Hydrochloride i.p—2.25 mg Riboflavine Sod. Phosphate i.p—2.5mg Pyridoxamine Hydrochloride i.p— 1mg Nicotinamide I, p— 22.5 mg Cyanocobalamin I.p—2.5mcg D-Panthenol i.p— 3mg L-Lysine Hydrochloride usp—375mg Choline Dihydrogen Citrate—87.5mg Copper Sulphate Pentahydrate b.p—100 mcg Potassium Iodide i.p—50 mg Zinc Sulphate i.p—22.5mg In a flavured syrupy base q.s |
10 | CHOLECALCIFEROL ORAL DROPS 60000 I.U | Each 5 ml contains: Vitamin D3 (Cholecalciferol) ip 60000 iu (In nano droplet form) In a flavoured sugar free base q.s Colour: Tartrazine Supara Appropriate overages of vitamin added to compensate for loss on |
11 | POTASSIUM MAGNESIUM CITRATE ORAL SOLUTION | Each 5ml contains: Potassium Citrate IP 1100 mg+ Magnesium Citrate USP 375 mg Colour: Caramel IP |
12 | MULTIVITAMIN, MULTIMINERAL & AMINOXIDANT SYRUP | Each 10 ml contains: Methylcobalamin I.P— 1mcg Lycopene u.s.p—10 %—100 mcg Lysine Hydrochloride u.s.p—30 mg Niacinamide i.p—15 mg Zinc Sulphate i.p—3 mg D-Panthenol i.p—2.5 mg Vitamin A ( As Palmitate) i.p—2500 i.u Vitamin E (Tocopheryl Acetate) i.p—5 i.u Vitamin B2 i.p—1 mg Vitamin B6 i.p—1 mg Sodium Selenite Pentahydrate b.p eq. to Elemental Selenium—10 In a flavoured syrupy base–q.s Colour: Approved colours used Appropriate overages of vitamins added to compensate for loss |
13 | PROTEIN HYDROLYSATE, MULTIVITAMINS & MUTIMINERALS SYRUP | Each 5 ml contains: Protein Hydrolysate (20% solution)— 333 mg Iron (ferric ammonium citraye i.p)— 15 mg Niacinamide I.P— 15 mg L-lysin Hydrochloride USP— 3.3 mg Magnesium Chloride I.P— 3.3 mg D-Panthenol I.P— 2.0 mg Vitamin B2 I.P— 1.6 mg Vitamin B1 I.P— 1.4 mg Vitamin B6 I.P— 0.5 mg Zinc — 0.2 mg (As a zinc sulphate IP) Maganese chloride USP— 0.1 nmg Vitamin B12 I.P— 1.0 mcg In a flavoured syrupy base — q.s Colour: Approved Colour Used |
14 | Calcium Carbonate & Vitamin D3 Suspension | Each 5ml contains: 0.625 gm of Calcium Carbonate I.P from an organic source (oyester shell) eq. to elemental calcium—250 mg Vitamin D3 I.P—125 IU In a flavoured sugar free base—q.s Colour: Approved colour used. |
15 | POTASSIUM MAGNESIUM CITRATE & PYRIDOXINE HYDROCHLORDE (VITAMIN B6 SYRUP) | Each 5ml contains: Potassium Magnesium Citrate—978 mg Pyridoxine Hydrochloride (Vit. B6) I.P—14mg In a flavoured non syrupy base—q.s Colour: Approved colour used. |
16 | BETA CAROTENE, ALPHA TOCOPHEROL ACETATE, CHOLECALCIFEROL, PYRIDOXIONE HYDROCHLORIDE, NIACINAMIDE, CYANOCOBALAMIN, BIOTIN, INOSITOL, LYSINE HYDROCHLORIDE, MAGANESE CHLORIDE TETRAHYDRATE, SODIUM MOLYBDATE, SODIUM SELENITE & POTASSIUM IODINE, CHROMIUM CHLORIDE, | Each 5ml contains: Betacarotene USP—38 mg (As Dispersion 2.5%) Alpha-Tocoherol Acetate I.P—5 mg Cholecalciferol I.P—1000 IU (As stabilized) Pyridoxine Hydrochloride I.P—1 mg Niacinamide I.P—15 mg Cynocobalamin I.P—1 mcg Biotin USP—10 mcg Inositol USP—10 mg L-Lysine Hydrochloride USP—30 mg Maganese Chloride Tertahydrate USP eq. to elemental Maganese—0.8 mg Sodium Molybdate Dihydrate BP eq. to elemental Molybdenum—8 mcg Sodium Selenite Pentahydrate B.P eq. to |
17 | FERROUS BIS GLYCINATE, AMINO ACID, POTASSIUM IODINE, METHYLCOBALAMIN SUSPENSION | Each 5ml contains: L-Methylfolate calcium 1mg Potassium Iodine—100 mcg Methylcobalamin—1500 mcg Ferrous Bis Glycinate eq. to Elemental Iron—25 mg In a flavoured syrupy base—q.s colour: Approved colour used. Appropriate overages of vitamins added to compensate for loss |
18 | MULTIVITAMIN, MULTIMINERALS & ANTIOXIDANT SYRUP | Each 10 ml contains: Methlcobalamin I.P—1 mcg Lycopene USP 10%—1000 mcg Lysine Hydrochloride USP—30 mg Niacinamide IP—15 mg Zinc Sulphate I.P—3 mg D-Panthenol I.P–2.5mg Vitamin A (as palmitate) I.P—2500 IU Vitamin E (Tocopheryl Acetate) IP—5 IU Vitamin B2 IP—1 mg Vitamin B6 IP—1 mg Sodium Selenite Pentahydrate B.P eq. to Elemental Selenium—10 mcg In a flavoured syrupy base—q.s Colour: Approved colours used. Appropriate overages of vitamin added to compensate for loss on |
19 | CALCIUM CARBONATE & VITAMIN D3 SUSPENSION | Each 5 ml contains: 0.625 gm of Calcium Carbonate I.P from an organic source (oyester shell) eq. to elemental calcium—250 mg Vitamin D3 I.P—125 IU In a flavoured sugar free base–q.s Colour: Approved colour used. |
20 | MULTIVITAMIN & MULTIMINERAL SYRUP | Each 5ml contains: Iron (as ferric ammonium citrate i.p)—15 mg Niacinamide USP—15 mg L-lysine Hydchloride USP—3.3 mg Magnesium chloride USP—3.3 mg D-Panthenol USP—2.0 mg Vitamin B2 USP—1.6 mg Vitamine B1 USP—1.4 mg Vitamin B6 USP—0.5 mg ZInc—0.2 mg (as a zinc sulphate IP) Manganese Chloride—0.1 mg Vitamin B12 USP—1.0 mcg In a flavoure syrupy base—q.s Colour: Approved colour used. |
21 | MULTIVITAMIN WITH ZINC ORAL DROPS | Each ml contains: Vitamins A Conentrated (oily form) IP (as palmitate)—2500 I.U Vitamin D3 (Cholecalciferol) IP—200 I.U Thiamine HCL IP—0.5 mg Riboflavin IP—0.5 mg (as Riboflavin Sodium Phosphate) Pyridoxine Hydrochloride IP—0.5 mg D-Panthenol IP—1.5 mg Nicotinamide IP—5.0 mg Ascorbic Acid IP—25 mg Vitamin E Acetate IP—2.5 I.U Zinc Sulphate Monohydrate USP eq. to elemental zinc—2.5 mg In a flavoured base Colour: Approved colour used. (Appropriate overages of vitamins added to compensate for loss |
22 | MULTIVITAMINS & MULTIMINERALS SYRUP | Each 15 ml (One Tablespoonful) contains: Mecobalamin I.P—500 mcg Vitamin B6 I.P—1.5 mg Niacinamide I.P—45 mg biotin USP—300 mcg Zinc Sulphate I.P eq. to Elemental zinc—7.5 mg Potassium Iodine I.P eq. to Elemental Iodine—75 mcg Ferric Ammonium Citrate I.P eq. to Elemental Iron—18 MG Copper Sulphate Pentahydate B.P eq. to Elemental Copper—0.45 mg Magnaese Sulphate Monohydrate U.S.P eq. to Elemetal Chromium Chloride U.S.P. eq. to Elemental Chromium—25 mcg L-Lysine Monohydratechloride U.S.P—50 mg Sodium Selenate Pentahydrate B.P eq. to Elemental Selenium—40 mcg Flavoured syrupy base.—q.s Colour: Approved colour used. Appropriate overages of vitamins are added |
23 | MULTIVITAMINS & MULTIMINERALS SYRUP | Each 5 ml contains: Vitamin A (as palmitate) IP—2500 IU Vitamin E ( as acetate) IP—7.5 IU Vitamin D3 IP—200 IU Thiamine Hydrochloride IP—2.25 mg Riboflavin IP—2.50 mg Pyridoxine Hydrochloride IP—1 mg Niacinamide IP—22.5 mg Cyanocobalamin IP—2.5 mg D-Panthenol IP—2.5 mg Ascorbic Acid IP—40 mg Zinc Sulphate eq. to Elemental Zinc—1 mg Chromium Chloride USP eq. to Elemental Chromium—8 mcg Sodium Molybdate USP eq. to Elemental Molybdenum—8 mcg Maganese Sulphate IP eq. to Elemental Maganese—0.8 mg Calcium Lactate IP eq. to Elemetal Calcium—1.25 mg Sodium Selenate USP eq. to Elemental Selenium—10 mcg Flavour syrupy base—q.s Colour: Approved colour used. Appropriate overages of vitamins added to compensate for loss |
24 | HAEMOGLOBIN SYRUP (FOR EXPORT ONLY) | Each 10 ml contains: Ferric Ammonium citrate USP—250 mg (eq. to elemental Iron 50 mg) Thiamine Hydrochloride BP—3 mg Pyridoxine Hydrochloride BP—1.5 mg Cyanocobalamin BP—5 mcg D-Panthenol USP—2.5 mg Niacinamide USP—25 mg In a flavoured syrupy base Appropriate overages of vitamins added to compensate the loss |
25 | ZINC GLUCONATE ORAL SOLUTION 20 MG | Each ml contains Zinc Gluconate–20 mg In a flavured non-syrupy base q.s Colour: Ponceau-4R |
CNS | ||
S. No. | Generic Name | Composition |
1 | SODIUM VALPORATE ORAL SOLUTION IP | Each 5 ml contains:
Sodium Valporate I.P— 200 mg in flavoured sysrupy base Colour: Approved colour used. |
2 | PIRACETAM SYRUP | Each 5 ml contains:
Piracetam I.P—500 mg In flavoured syrupy base Colour: Approved colour used. |
3 | MELATONIN SYRUP | Each 5 ml contains:
Melatonin B.P—3 mg In a flavoured syrupy base—q.s colour: Approved colour used |
4 | MELATONIN SYRUP | Each 15 ml contains:
Benzydamine Hcl B.P—22.5 mg Chlorhexidine Gluconate solution IP eq. to Chlorhexidine—18 mg In flavoured aqueous base Colour: Approved colour used. |
5 | PHENYTOIN ORAL SUSPENSION IP | Each ml contains:
Phenytoin IP—25 mg In a flavoured base—q.s Colour: Approved colour used. |
6 | PHENYTOIN ORAL SUSPENSION IP | Each ml contains:
Phenytoin IP—25 mg In a flavoured base—q.s Colour: Approved colour used. |
7 | RISPERIDONE ORAL SOLUTION USP | Each ml contains:
Risperidone I.P—1 mg In a flavoured aqueous base Colour: Approved colour used. |
8 | LEVETIRACETAM ORAL SOLUTION IP 100 MG/ML | Each 5 ml contains:
Levetiracetam IP—100 mg In a flavoured syrupy base Colour: Approved colour used. |
9 | SODIUM VALPORATE ORAL SOLUTION B.P.
| Each 1 ml contains:
Sodium Valporate B.P.—50 mg Excipients—q.s Colour: Approved colour used. |
ANTACID | ||
S. No. | Generic Name | Composition |
1 | MAGALDRATE, OXETACAINE & SIMETHICONE ORAL SUSPENSION (540mg+10mg+50mg+1000mg) | Each 5ml contains Magaldrate i.p eq to Anhydrous Magaldrate–540 mg Oxetacaine b.p– 10mg Simethicone i.p–50 mg Sorbitol Solution (70%) i.p-1000mg (Non-Crystallising) In a flavoured non-syrupy base q.s Colour : Quinoline Yellow |
2 | MAGALDRATE, OXETACAINE & SIMETHICONE ORAL SUSPENSION | Each 5ml contains Magaldrate i.p eq to Anhydrous Magaldrate–540 mg Oxetacaine b.p– 10mg Simethicone i.p–50 mg Sorbitol Solution (70%) i.p-1000mg (Non-Crystallising) In a flavoured non-syrupy base q.s Colour : Quinoline Yellow |
3 | SUCRALFATE & OXETACAINE ORAL SUSPESION | Each 10ml contains Sucralfate usp–1g Oxetacaine bp—20mg In a flavured palatable base q.s Colour:- Sunset Yellow FCF |
4 | OXETACAINE, ALUMINIUM HYDROCHLORIDE & MAGNESIUM HYDROCHLORIDE ORAL SUSPESION | Each 5ml contains Oxetacaine b.p—10mg Aluminium Hydroxide—291mg (As dried aluminium hydroxide i.p 380mg) Magnesium Hydroxide ip—98mg In a flavured non-syrupy base q.s |
5 | SODIUM BICARBONATE ORAL SUSPENSION 1000 MG | Each 15 ml contains Sodium Bicarbonate i.p—1000mg In a flavured syrupy base Colour: Tartrazine |
6 | MAGALDRATE & SIMETHICONE ORAL SUSPENSION I.P | Each 5ml contains Magaldrate i.p eq to Anhydrous Magaldrate—400mg Simethicone i.p—60mg In a flavured non-syruy base Colour:-Brilliant Blue FCF & Tartrazine |
7 | ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE & SIMETHICONE ORAL SUSPENSION I.P | Each 5 ml contains Alumimium hydroxide—250 mg Magnesium hydroxide i.p–250 mg Simethicone—50 mg In flavoured non-syrupy base q.s Colour: Brilliant Blue FCF & Tartrazine |
8 | SODIUM ALGINATE, SODIUM BICARBONATE & CALCIUM CARBONATE ORAL SUSPENSION | Each 5 ml contains Sodium Alginate i.p—250mg Sodium Bicarbonate i.p—133.5mg Calcium Carbonate i.p—80 mg In a flavured non-syrupy base approved colours used. |
9 | LIQUID PARAFFIN, MILK OF MAGNESIA & SODIUM PICOSULPHATE | Each 5 ml contains: Liquid Paraffin I.P— 1.25 ml Milk of Magnesia I.P—3.75 ml Sodium Picosulfate B.P— 3.33 mg In a Non Syrupy Base Colour: Approved Colour Used. |
10 | ALUMINIUM, MAGNESIUM & SIMETHICONE ORAL SUSPENSION IP | Each 5 ml contains: Aluminium Hydroxide—229.5 mg eq. to Dried Aluminium Hydroxide Gel IP—300 mg Magnesium Hydroxide I.P—250 mg Simethicone I.P—40 mg In flavoured non-syrupy base |
11 | DRIED ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE AND QXETACAINE ORAL SUSPENSION | Each 5 ml contains: Qxetacaine BP—10 mg Aluminium Hydroxide—0.291 gm (added as Aluminium Hydroxide paste eq. to 0.380 gm of Dried Aluminium Hydroxide Gel IP) Magnesium Hydroxide IP—98 mg Colour: Approved colour used. |
12 | MAGALDRATE, SIMETHICONE & OXETACAINE ORAL SUSPENSION | Each 5 ml contains: Magaldrate IP eq. to Anhydrous Magaldrate—480 mg Simethicone IP—20 mg Oxetacaine BP—10 mg Flavoured sorbitol base Colour: Quinoline yellow |
13 | DRIED ALUMINIUM HYDROXIDE GEL, MAGNESIUM HYDROXIDE ACTIVATED DIMETHICONE & QXETACAINE SUSPENSION | Each 5 ml contains : Aluminium Hydroxide paste eq. to Dried Aluminium Hydroxide Gel IP—300 mg Magnesium Hydroxide paste eq. to Magnesium Hydroxide IP—150 mg Acitvated Dimethicone IP—125 mg Oxetacaine BP—10 mg In a flavooured sugar free base—q.s Colour: Sunset Yellow |
14 | SUCRALFATE & OXETACAINE SUSPESION | Each 10 ml contains: Sucralfate USP—1000 mg Oxetacaine BP—20 mg In a flavoured base BP In a flavoured base Colour: Approved colour used. |
15 | ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE, ACTIVATED DIMETHICONE (SIMETHICONE) & OXETACAINE ORAL SUSPENSION | Each 5ml of suspension contains: Aluminium Hydroxide Paste eq. to Dried Aluminium Hydroxide I.P—250 mg Magnesium Hydroxide Paste eq. to Magnesium Hydroxide I.P—250 mg Activated Dimethicone I.P (Simethicone)—50 mg Oxetacaine B.P—10 mg In a flavoured base—q.s Colour: Approved colour used |
16 | POLYETHYLENE GLYCOL (MACROGOL 3350), SODIUM CHLORIDE, SODIUM HYDROGEN CARBONATE & POTASSIUM CHLORIDE CONCENTRATE FRO ORAL SOLUTION | Each 25 ml contains: Polyethylene glycol 3350 USP—13.125 gm Sodium Chloride I.P—0.3507 gm Sodium Hydrogen Carbonate I.P—0.1785 gm Potassium Chloride I.P—0.0466 gm Excipients–q.s |
17 | SODIUM SULFATE+POTASSIUM SULPHATE & MAGNESIUM SULFATE ORAL BOWEL PREPRATION SOLUTION | Each Bowel Preparation Kit Contains: Two Bottle of each with 177 ml of oral solution. Each Bottle with 177 ml of Bowel Preparation solution Contains: Sodium Sulfate Anhydrous USP—17.5 g Potassium Sulfate BP—3.13 g Magnesium Sulfate Anhydrous USP—1.6 g In a flavoured base |
18 | RANITIDINE HYDROCHLORIDE SYRUP IP | Each 5ml contains: Ranitidine Hydrochloride IP eq. to Ranidine—75 mg Flavoured syrup base Colour: Approved colour used. |
19 | MAGALDRATE, SIMETHICONE & DOMPERIDONE ORAL SUSP | Each 10 ml contains: Magaldrate IP eq. to Anhydrous magaldrate—540 mg Simethicone IP—20 mg Domperidone IP—10 mg In a pleasantly flavoured sorbitol base Colour: Approved colour used. |
20 | RANITIDINE ORAL SOLUTION IP | Each 5ml contains: Ranitidine Hydrochloride IP eq. to Ranidine—75 mg In a flavoured syrup base Colour: Approved colour used. |
21 | ALUMINIUM, MAGNESIUM & SIMETHICONE ORAL SUSPENSION IP | Each 5 ml contains Dried Aluminium Hydroxide I.P—250 mg Magnesium Hydroxide I.P—250 mg Simethicone I.P—50 mg Excipients—q.s Colour: Approved colour used. |
22 | FAMOTIDINE SUSPENSION (FOR EXPORT ONLY) | Each 5 ml contains: Famotidine BP—10 mg In a flavoured syrupy base |
23 | SUCRALFATE ORAL SUSPENSION | Each 10ml contains: Sucralfate i.p—1g In a flavured palatable base q.s |
ANTIVIRAL | ||
S. No. | Generic Name | Composition |
1 | ACICLOVIR ORAL SUSPENSION IP | Each 5 ml contains:
Aciclovir IP—200 mg In a flavoured syrupy base Colour: Approved colour used |
DIGESTIVE SYSTEM | ||
S. No. | Generic Name | Composition |
1 | DILL OIL, FENNEL OIL WITH SIMETHICONE ORAL DROPS (0.005mg+0.0007mg+40mg) | Each ml contains Dill Oil b.p–0.005ml Fennel Oil b.p–0.0007ml Simethicone i.p–40 mg In a flavured palatable base q.s |
2 | DIGESTIVE ENZYME, DILL OIL, FENNEL OIL & SIMETHICONE ORAL DROP | Each ml contains : Diastase (1:1200) 33.33 mg Pepsin (1:3000) 5 mg Simethicone Emulsion USP Eq. to simethicone 40 mg Dill Oil BP 0.0002 ml Fennel Oil U.S.P. 0.0003 ml In a flavoured syrupy base q.s. Colour : Sunset Yellow FCF |
3 | ALPHA AMYLASE & PEPSIN SYRUP | Each 5ml contains Alpha-Amylase i.p–100 mg (Bacterial 1800) Pepin i.p—50 mg In a flavured non-syrupy base q.s Colour: Caramel USP NF |
4 | DIGESTIVE ENZYME, DILL OIL, FENNEL OIL & SIMETHICONE ORAL DROP | Each ml contains: Diastase (1:1200)—33.33mg Pepsin (1:3000)—5mg Simethicone Emulsion usp eq.to Simethicone—40mg Dill Oil b.p—0.005ml Fennel Oil usp—0.0007ml In aflavured syrupy base q.s |
5 | DIGESTIVE ENZYME WITH CARMINATIVE ORAL DROPS | Each ml contains (approx. 20 drops) Fungal Diastase (1: 2000 ) I.P—20 mg (Fungal Diastase deliverd from Aspergillus-Oryazae. Digest not less Than 40 gm. Of cooked starch Cinnamon Oil B.P—200 mcg Caraway Oil B.P—400 mcg Cardamon Oil B.P—400 mcg In a flavoured non-syrupy base—q.s Colour: Caramel usp nf |
6 | FUNGAL DIASTASE & PEPSIN SYRUP | Each 5 ml contains: Fungal Diastase I.P (1: 1200)—50 mg (Digests not less than 60 gm of cooked starch) Pepsin I.P (1:3000)—10 mg (Digests not less than 30 gm of coagulate albumen) Sorbitol Solution (70%)—q.s In a flavoured palatable base Colour: Approved colour used. |
7 | ALPHA-AMYLASE & PAPAIN SYRUP | Each 5 ml contains: Alpha-Amylase IP—100 mg (Bacterial 1: 800) Papain IP—50 mg In a flavoured non-syrupy baes—q.s Colour: Approved colour used. |
LAXATIVE | ||
S. No. | Generic Name | Composition |
1 | LACTULOSE SOLUTION USP 3.350 G | Each 5 ml contains Lactulose Concentrate usp eq.to Lactulose— 3.350g In a palatable non-syrupy base q.s Colour:Caramel i.p |
2 | POLYERHYLENE GLYCOL ORAL LAXATIVE LIQUID | Each 25 ml contains: Polyethylene glycol 4000 i.p—10mg Excipients–q.s |
3 | LACTULOSE SOLUTION USP | Each 15 ml contains: Lactulose Concentrate U.S.P—10 g In a palatable non-syrupy base—q.s colour: Approved colour used. |
4 | LACTULOSE SOLUTION | Each 15 ml contains: Lactulose Concentrate U.S.P—10 gm In a palatable non-syrupy base—q.s colour: Approved colour used. |
ANTIEMETIC | ||
S. No. | Generic Name | Composition |
1 | ONDASNSETRON ORAL SOLUTION I.P | Each 5 ml contains:-
Ondansetron Hydrochloride i.p eq. to Ondansetron— 2 mg In a flavured syrupy base q.s Colour:- Ponceau-4R |
2 | DOMPERIDONE SUSPENSION I.P | Each 5ml contains:
Domperidone i.p—5 mg In a flavoured syrupy base q.s Colour: Sunset Yellow FCF |
3 | ONDANSETRON ORAL SOLUTION USP
| Eachn 5 ml contains:
Ondansetron Hydrochloride USP eq. to Ondansetron—4 mg In a flavoured syrupy base |
4 | ONDANSETRON ORAL SOLUTION USP
(FOR EXPORT ONLY) | Eachn 5 ml contains:
Ondansetron Hydrochloride USP eq. to Ondansetron—2 mg In a flavoured syrupy base |
ANTIFUNGAL | ||
S. No. | Generic Name | Composition |
1 | POSACONAZOLE ORAL SUSPENSION 40 | Each 5 ml contains:
Posaconazole—40 mg Sodium Benzoate I.P—2 mg In a flavoured palatable base—q.s Colour: Approved Colour Used. |
URINARY DISORDER | ||
S. No. | Generic Name | Composition |
1 | DI-SODIUM HYDROGEN CITRATE SYRUP | Each 5ml contains
Disodium Hydrogen Citrate B.P—1.4 g In a palatable non-syrupy base Colour: Tartrazine |
2 | NITROFURANTOIN SUSPENSION | Each 5 ml contains:
Nitrofurantoin IP—25 mg Flavoured syrupy base—q.s Colou: Approved colour used. |
IRON SUPPLEMENT | ||
S. No. | Generic Name | Composition |
1 | FERROUS ASCORBATE & FOLIC ACID ORAL SUSPENSION (30mg+550mcg) | Each 5 ml contains : Ferrous Ascorbate eq. to Elemental Iron 30 mg Folic Acid I.P. 550 mcg In a flavoured syrupy base q.s. Colour : Erythrosine Appropriate overages of vitamin added to compensate for loss on |
2 | FERRIC AMMONIUM CITRATE, FOLIC ACID, CYNOCOBALAMIN SYRUP | Each 5ml contains: Ferric Ammonium Citrate I.P—160 mg (eq. to 33 mg of elemental iron) Folic Acid I.P—1mg Cynocobalamin I.P—7.5 mcg In a flavoured syrupy base—q.s Colour: Approved Colours Used. |
3 | FERRIC AMMONIUM CITRATE, FOLIC ACID, CYNOCOBALAMIN SYRUP | Each 5ml contains: Ferric Ammonium Citrate I.P—200 mg (eq. to 40 mg of elemental iron) Folic Acid I.P—1mg Cynocobalamin I.P—7.5 mcg In a flavoured syrupy base—q.s Colour: Approved Colours Used. |
4 | FERROUS FUMARATE, FOLIC ACID, CYANOCOBALAMIN SYRUP | Each 5 ml contains: Ferrous Fumarate IP eq. to Elemental iron—100 mg Folic Acid IP—0.5 mg Cyanocobalamin (Vit. B12) IP—5 mcg Flavoured syrupy base—q.s Colour: Approved colour used. Appropriate overags added to compensate for loss on storage. |
CORTICOSTEROID | ||
S. No. | Generic Name | Composition |
1 | DEFLAZACORT ORAL SUSPENSION | Each 5 ml contains:-
Deflazacort—6 mg in a flavoured syrupy base q.s Colour: Quinoline Yellow |
PREBIOTICS | ||
S. No. | Generic Name | Composition |
1 | PREBIOTIC & PROBIOTIC FOR ORAL SUSPENSION | Each 5 ml (after reconstitution) contains: Lactobacillus Acidophilus—0.2 Billion Spores Lactobacillus Rhamnosus—0.2 Billion Spores Bifidobacterium Longum—0.2 Billion Spores Bifidobacterium Bifidus—0.125 Billion Spores Saccharomyces Boulardii—0.025 Billion Spores Fructo-Oligosaccharides—25 mg Excipients—q.s Colour: Sunset Yellow FCF |
Automated page speed optimizations for fast site performance